Brookdale Senior Living (B7S) Stock Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

B7S Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Brookdale

Senior Living

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

B7S Stock 12 Month Forecast

Average Price Target

€17.03

▲(28.99% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Brookdale Senior Living in the last 3 months. The average price target is €17.03 with a high forecast of €19.98 and a low forecast of €14.77. The average price target represents a 28.99% change from the last price of €13.20.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"€5","20":"€20","8.75":"€8.75","12.5":"€12.5","16.25":"€16.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":19.98102667,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€19.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.027309684,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€17.03</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.76858493,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€14.77</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,8.75,12.5,16.25,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.4,12.983155897692308,13.566311795384616,14.149467693076923,14.732623590769231,15.315779488461539,15.898935386153845,16.482091283846152,17.06524718153846,17.648403079230768,18.231558976923075,18.814714874615383,19.39787077230769,{"y":19.98102667,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.4,12.755946898769231,13.111893797538462,13.467840696307693,13.823787595076922,14.179734493846153,14.535681392615384,14.891628291384615,15.247575190153846,15.603522088923075,15.959468987692308,16.315415886461537,16.67136278523077,{"y":17.027309684,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.4,12.58219884076923,12.764397681538462,12.946596522307692,13.128795363076923,13.310994203846153,13.493193044615385,13.675391885384615,13.857590726153846,14.039789566923076,14.221988407692308,14.404187248461538,14.586386089230768,{"y":14.76858493,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.7,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.3,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.95,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.45,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.05,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.1,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.7,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.2,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.5,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.8,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.4,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€19.98

Average Price Target€17.03

Lowest Price Target€14.77

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Joanna Gajuk

Bank of America Securities

―

Buy

―

Reiterated

07/17/26

Analysts' Top Healthcare Picks: Trevi Therapeutics (TRVI), Brookdale Senior Living (BKD)

Ben Hendrix

RBC Capital

€14.77

Buy

11.88%

Upside

Reiterated

07/09/26

RBC Capital Sticks to Its Buy Rating for Brookdale Senior Living (BKD)

Andrew Mok CFA

Barclays

€15.64

Buy

18.46%

Upside

Reiterated

07/09/26

Barclays Sticks to Their Buy Rating for Brookdale Senior Living (BKD)

Rob Simone

Compass Point

€19.11

Buy

44.79%

Upside

Initiated

06/15/26

Brookdale Senior Living initiated with a Buy at Compass PointBrookdale Senior Living initiated with a Buy at Compass Point

Raj Kumar CFA

Stephens

€15.64

Buy

18.46%

Upside

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), ICU Medical (NASDAQ: ICUI) and Brookdale Senior Living (NYSE: BKD)

Brian Tanquilut

Jefferies

€19.98

Buy

51.37%

Upside

Reiterated

05/07/26

Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Brookdale Senior Living (BKD)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Joanna Gajuk

Bank of America Securities

―

Buy

―

Reiterated

07/17/26

Analysts' Top Healthcare Picks: Trevi Therapeutics (TRVI), Brookdale Senior Living (BKD)

Ben Hendrix

RBC Capital

€14.77

Buy

11.88%

Upside

Reiterated

07/09/26

RBC Capital Sticks to Its Buy Rating for Brookdale Senior Living (BKD)

Andrew Mok CFA

Barclays

€15.64

Buy

18.46%

Upside

Reiterated

07/09/26

Barclays Sticks to Their Buy Rating for Brookdale Senior Living (BKD)

Rob Simone

Compass Point

€19.11

Buy

44.79%

Upside

Initiated

06/15/26

Brookdale Senior Living initiated with a Buy at Compass PointBrookdale Senior Living initiated with a Buy at Compass Point

Raj Kumar CFA

Stephens

€15.64

Buy

18.46%

Upside

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), ICU Medical (NASDAQ: ICUI) and Brookdale Senior Living (NYSE: BKD)

Brian Tanquilut

Jefferies

€19.98

Buy

51.37%

Upside

Reiterated

05/07/26

Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Brookdale Senior Living (BKD)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

MLYSMineralys Therapeutics, Inc.

ZURAZura Bio

TNYATenaya Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Brookdale Senior Living

3 Months

Ben HendrixRBC Capital

Success Rate

17/24 ratings generated profit

Average Return

+13.40%

Copying Ben Hendrix's trades and holding each position for 3 Months would result in 70.83% of your transactions generating a profit, with an average return of +13.40% per trade.

1 Year

Ben HendrixRBC Capital

Success Rate

18/24 ratings generated profit

Average Return

+50.15%

Copying Ben Hendrix's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +50.15% per trade.

2 Years

Ben HendrixRBC Capital

Success Rate

22/24 ratings generated profit

Average Return

+94.55%

Copying Ben Hendrix's trades and holding each position for 2 Years would result in 91.67% of your transactions generating a profit, with an average return of +94.55% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

B7S Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, B7S has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. B7S average Analyst price target in the past 3 months is 17.03.

Each month's total comprises the sum of three months' worth of ratings.

B7S Financial Forecast

B7S Earnings Forecast

Next quarter’s earnings estimate for B7S is -€0.05 with a range of -€0.07 to -€0.03. The previous quarter’s EPS was -€0.03. B7S beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 36.78% of the time in the same period. In the last calendar year B7S has Performed in-line its overall industry.

B7S Sales Forecast

Next quarter’s sales forecast for B7S is €638.04M with a range of €622.31M to €647.90M. The previous quarter’s sales results were €663.39M. B7S beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.91% of the time in the same period. In the last calendar year B7S has Performed in-line its overall industry.

B7S Stock Forecast FAQ

What is DE:B7S’s average 12-month price target, according to analysts?

Based on analyst ratings, Brookdale Senior Living’s 12-month average price target is 17.03.

What is DE:B7S’s upside potential, based on the analysts’ average price target?

Brookdale Senior Living has 28.99% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Brookdale Senior Living a Buy, Sell or Hold?

Brookdale Senior Living has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is Brookdale Senior Living’s share price target?

The average share price target for Brookdale Senior Living is 17.03. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €19.98 ,and the lowest forecast is €14.77. The average share price target represents 28.99% Increase from the current price of €13.2.

What do analysts say about Brookdale Senior Living?

Brookdale Senior Living’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of Brookdale Senior Living?

To buy shares of DE:B7S, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Brookdale Senior Living (B7S) Stock Forecast & Price Target

B7S Analyst Ratings

B7S Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Brookdale Senior Living

B7S Analyst Recommendation Trends

B7S Financial Forecast

B7S Earnings Forecast

B7S Sales Forecast

B7S Stock Forecast FAQ

Detailed List of Analyst Forecasts